Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?

被引：0
|
作者：
Daniel Martin Klotz
Pauline Wimberger
机构：
[1] German Cancer Consortium (DKTK),Dresden and German Cancer Research Center (DKFZ)
[2] University Hospital Carl Gustav Carus,Department of Gynecology and Obstetrics, Medical Faculty
[3] Technische Universität Dresden,undefined
[4] National Center for Tumor Diseases (NCT),undefined
来源：
Archives of Gynecology and Obstetrics | 2020年 / 302卷
关键词：
Ovarian cancer; PARP inhibitors; Drug resistance; Clinical trials; Drug targets;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1087 / 1102
页数：15
相关论文
共 50 条
  • [1] Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?
    Klotz, Daniel Martin
    Wimberger, Pauline
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 302 (05) : 1087 - 1102
  • [2] Overcoming PARP inhibitor resistance in ovarian cancer
    Pina, Pamela Soberanis
    Lheureux, Stephanie
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (03) : 364 - 376
  • [3] Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer
    McMullen, Michelle
    Karakasis, Katherine
    Madariaga, Ainhoa
    Oza, Amit M.
    [J]. CANCERS, 2020, 12 (06) : 1 - 18
  • [4] PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies
    Miller, Rowan E.
    El-Shakankery, Karim H.
    Lee, Jung-Yun
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 33 (03)
  • [5] Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?
    Ray-Coquard, Isabelle
    Vanacker, Helene
    Le Saux, Olivia
    Tredan, Olivier
    [J]. EBIOMEDICINE, 2020, 61
  • [6] Mechanism of PARP inhibitor resistance and potential overcoming strategies
    Fu, Xiaoyu
    Li, Ping
    Zhou, Qi
    He, Ruyuan
    Wang, Guannan
    Zhu, Shiya
    Bagheri, Amir
    Kupfer, Gary
    Pei, Huadong
    Li, Juanjuan
    [J]. GENES & DISEASES, 2024, 11 (01) : 306 - 320
  • [7] Developing patient-derived organoids to predict PARP inhibitor response and explore resistance overcoming strategies in ovarian cancer
    Tao, Mengyu
    Sun, Fan
    Wang, Juan
    Wang, Yujing
    Zhu, Hongrui
    Chen, Meiqi
    Liu, Liyun
    Liu, Li
    Lin, Houwen
    Wu, Xia
    [J]. PHARMACOLOGICAL RESEARCH, 2022, 179
  • [8] Olaparib: a promising PARP inhibitor in ovarian cancer therapy
    Chen, Ying
    Zhang, Lei
    Hao, Quan
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 288 (02) : 367 - 374
  • [9] Olaparib: a promising PARP inhibitor in ovarian cancer therapy
    Ying Chen
    Lei Zhang
    Quan Hao
    [J]. Archives of Gynecology and Obstetrics, 2013, 288 : 367 - 374
  • [10] Strategies in Overcoming Homologous Recombination Proficiency and PARP Inhibitor Resistance
    Goel, Nidhi
    Foxall, McKenzie E.
    Scalise, Carly Bess
    Wall, Jaclyn A.
    Arend, Rebecca C.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2021, 20 (09) : 1542 - 1549
12345